It just strikes me that if we can correctly define the characteristics of the bad behavior that everybody on this committee sees and acknowledges exists, then going the long way around to trying to figure out how your drug approval process can resolve that problem is a very inefficient way to do it.
He criticizes the inefficiency of the drug approval process in addressing market manipulation.
Share & report
More from Sheldon Whitehouse
The good news is that the American people hate dark money with a passion, and they hate it just as much, if not more, in districts that went for Trump as in districts that went for Biden.
Turns out, none of [the science] really matters while the operation is controlling things in Congress.
The thing that's particularly dangerous about it is that this is probably a test case.
Republicans just overruled the Parliamentarian, violated the plain text of the Congressional Review Act, changed the Clean Air Act, and broke the filibuster.
Other voices in this conversation
